Chemoinformaics analysis of Phyllocladan-16alpha-ol
| Molecular Weight | 290.491 | nRot | 0 |
| Heavy Atom Molecular Weight | 256.219 | nRig | 19 |
| Exact Molecular Weight | 290.261 | nRing | 4 |
| Solubility: LogS | -5.478 | nHRing | 0 |
| Solubility: LogP | 5.434 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 56.873 |
| nHD | 1 | BPOL | 34.109 |
| QED | 0.652 |
| Synth | 5.435 |
| Natural Product Likeliness | 3.275 |
| NR-PPAR-gamma | 0.024 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.077 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.709 |
| MDCK | 0.0000128 |
| BBB | 0.189 |
| PPB | 0.963361 |
| VDSS | 1.5 |
| FU | 0.030592 |
| CYP1A2-inh | 0.084 |
| CYP1A2-sub | 0.259 |
| CYP2c19-inh | 0.113 |
| CYP2c19-sub | 0.884 |
| CYP2c9-inh | 0.288 |
| CYP2c9-sub | 0.367 |
| CYP2d6-inh | 0.141 |
| CYP2d6-sub | 0.419 |
| CYP3a4-inh | 0.702 |
| CYP3a4-sub | 0.237 |
| CL | 6.381 |
| T12 | 0.166 |
| hERG | 0.111 |
| Ames | 0.007 |
| ROA | 0.194 |
| SkinSen | 0.922 |
| Carcinogencity | 0.276 |
| EI | 0.886 |
| Respiratory | 0.94 |
| NR-Aromatase | 0.231 |
| Antiviral | No |
| Prediction | 0.65174 |